Unusual sclerosing haemangiomas and sclerosing haemangioma-like lesions, and the value of TTF-1 in making the diagnosis

Histopathology

Volumn 41, Issue 5, 2002, Pages 404-413

  Nicholson, A G ^a   Magkou, C ^a   Snead, D ^c   Vohra, H A ^c   Sheppard, M N ^a   Goldstraw, P ^a   Beddow, E ^a   Hansell, D M ^a   Corrin, B ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

Cyst; Sclerosing haemangioma; TTF 1

Indexed keywords

APOLIPOPROTEIN A; THYROID TRANSCRIPTION FACTOR 1;

ADULT; ARTICLE; CARCINOID; CASE REPORT; CELL TYPE; CLINICAL FEATURE; CYTOLOGY; DIAGNOSTIC VALUE; EOSINOPHILIA; EPITHELIUM; FEMALE; HISTIOCYTOMA; HISTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL;

AGED; CYSTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; RADIOGRAPHY, THORACIC; SCLEROSIS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 18744373311     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01522.x     Document Type: Article

References (25)

1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer 1956; 9; 53-75.
2. Huszar M, Suster S, Herczeg E, Geiger B. Sclerosing hemangioma of the lung. Immunohistochemical demonstration of mesenchymal origin using antibodies to tissue-specific intermediate filaments. Cancer 1986; 58; 2422-2427.
3. Xu HM, Li WH, Hou N et al. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: Identified by immunohistochemical and ultrastructural study. Am. J. Surg. Pathol. 1997; 21; 1013-1022.
4. Nagata N, Dairaku M, Ishida T, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung. Immunohistochemical characterization of its origin as related to surfactant apoprotein. Cancer 1985; 55; 116-123.
5. Chan KW, Gibbs AR, Lo WS, Newman GR. Benign sclerosing pneumocytoma of lung (sclerosing haemangioma). Thorax 1982; 37; 404-412.
6. Haimoto H, Tsutsumi Y, Nagura H, Nakashima N, Watanabe K. Immunohistochemical study of so-called sclerosing haemangioma of the lung. Virchows Arch. A Pathol. Anat. Histopathol. 1985; 407; 419-430.
7. Satoh Y, Tsuchiya E, Weng SY et al. Pulmonary sclerosing hemangioma of the lung. A type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies. Cancer 1989; 64; 1310-1317.
8. Yousem SA, Wick MR, Singh G et al. So-called sclerosing hemangiomas of lung. An immunohistochemical study supporting a respiratory epithelial origin. Am. J. Surg. Pathol. 1988; 12; 582-590.
9. Alvarez-Fernandez E, Carretero-Albinana L, Menarguez-Palanca J. Sclerosing hemangioma of the lung. An immunohistochemical study of intermediate filaments and endothelial markers. Arch. Pathol. Lab. Med. 1989; 113; 121-124.
10. Nagata N, Dairaku M, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells. Am. J. Clin. Pathol. 1987; 88; 552-559.
11. Leong AS, Chan KW, Seneviratne HS. A morphological and immunohistochemical study of 25 cases of so-called sclerosing haemangioma of the lung. Histopathology 1995; 27; 121-128.
12. Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): A new clue to its histogenesis. Am. J. Surg. Pathol. 2000; 24; 1531-1536.
13. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am. J. Surg. Pathol. 2000; 24; 906-916.
14. Niho S, Suzuki K, Yokose T, Kodama T, Nishiwaki Y, Esumi H. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am. J. Pathol. 1998; 152; 1065-1069.
15. Papla B. Sclerosing hemangioma of the lung - Benign sclerosing pneumocytoma. Pol. J. Pathol. 1999; 50; 99-106.
16. RodriguezSoto J, Colby TV, Rouse RV. A critical examination of the immunophenotype of pulmonary sclerosing hemangioma. Am. J. Surg. Pathol. 2000; 24; 442-450.
17. Spencer H, Nambu S. Sclerosing haemangiomas of the lung. Histopathology 1986; 10; 477-487.
18. Tanaka I, Inoue M, Matsui Y et al. A case of pneumocytoma (socalled sclerosing hemangioma) with lymph node metastasis. Jpn. J. Clin. Oncol. 1986; 16; 77-86.
19. Burke LM, Rush WI, Khoor A et al. Alveolar adenoma: A histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum. Pathol. 1999; 30; 158-167.
20. Semeraro D, Gibbs AR. Pulmonary adenoma: A variant of sclerosing haemangioma of lung? J. Clin. Pathol. 1989; 42; 1222-1223.
21. Nicholson AG, McCormick CJ, Shimosato Y, Butcher DN, Sheppard MN. The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumours. Histopathology 1995; 27; 57-60.
22. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 2000; 36; 8-16.
23. Bejarano PA, Baughman RP, Biddinger PW et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod. Pathol. 1996; 9; 445-452.
24. Mahadeva R, Stewart S, Wallwork J. Metastatic endometrial stromal sarcoma masquerading as pulmonary lymphangioleiomyomatosis. J. Clin. Pathol. 1999; 52; 147-148.
25. Traweek T, Rotter AJ, Swartz W, Azumi N. Cystic pulmonary metastatic sarcoma. Cancer 1990; 65; 1805-1811.